SWINE FEVER VACCINE MARKET ANALYSIS

Market News

Recent Developments

In May 2022, Boehringer Ingelheim, a global leading company in animal health, announced its latest innovation: TwistPak, a revolutionary mixing platform. It enables swine producers to combine two vaccines, Ingelvac CircoFLEX and Ingelvac MycoFLEX, in a convenient, fast and flexible way.

In June 2020, Boehringer Ingelheim announced that it’s China-developed Classical Swine Fever Vaccine, Live (C-strain, PK/WRL Cell Line Origin) (English commercial name: Ingelvac CSF MLV) has just received a "New Veterinary Drug Registration Certificate" from the Ministry of Agriculture and Rural Affairs of China. It is the first Classical Swine Fever live vaccination co-developed by a foreign corporation and Chinese research organizations.

Increasing research and development activities by government and non-government organizations and key players in the market are expected to drive the market growth during the forecast period.

Increasing efforts by the governments of various countries and key players in the market to develop swine fever vaccines are expected to drive the market growth over the forecast period. For instance, in June 2022, Vietnam had developed an African swine fever vaccine, NAVET-ASFVAC, for pigs in partnership with the U.S. The Vietnamese researchers worked with the U.S. scientists on the NAVET-ASFVAC jab since 2020.